Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Diehl, Philipp"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-6 z 6
    Tytuł:
    An Activation-Specific Anti-Mac-1 Designed-Ankyrin-Repeat-Protein Attenuates Colitis in Mice.
    Autorzy:
    Bojti I; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Street 55, 79106 Freiburg, Germany.
    Wang Q; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Street 55, 79106 Freiburg, Germany.
    Bojti T; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Street 55, 79106 Freiburg, Germany.
    Bojti F; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Street 55, 79106 Freiburg, Germany.
    Siegel PM; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Street 55, 79106 Freiburg, Germany.
    Heidt T; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Street 55, 79106 Freiburg, Germany.
    Moser M; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Street 55, 79106 Freiburg, Germany.
    Bode C; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Street 55, 79106 Freiburg, Germany.
    Westermann D; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Street 55, 79106 Freiburg, Germany.
    Peter K; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, VIC 3004, Australia.; Department of Medicine, Central Clinical School, Monash University, Melbourne, VIC 3004, Australia.; Department of Cardiometabolic Health, University of Melbourne, Melbourne, VIC 3004, Australia.
    Diehl P; Department of Cardiology and Angiology, University Heart Center Freiburg-Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Street 55, 79106 Freiburg, Germany.
    Pokaż więcej
    Źródło:
    Life (Basel, Switzerland) [Life (Basel)] 2023 Jun 28; Vol. 13 (7). Date of Electronic Publication: 2023 Jun 28.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The serum proteome of VA-ECMO patients changes over time and allows differentiation of survivors and non-survivors: an observational study.
    Autorzy:
    Siegel PM; Department of Cardiology and Angiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany. .
    Barta BA; Institute for Surgical Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Orlean L; Department of Cardiology and Angiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Steenbuck ID; Department of Cardiology and Angiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Institute for Surgical Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Cosenza-Contreras M; Institute for Surgical Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Wengenmayer T; Interdisciplinary Medical Intensive Care (IMIT), Medical Center, University of Freiburg, Freiburg, Germany.
    Trummer G; Department of Cardiovascular Surgery, Medical Center, University of Freiburg, Freiburg, Germany.
    Wolf D; Department of Cardiology and Angiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Westermann D; Department of Cardiology and Angiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Schilling O; Institute for Surgical Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Diehl P; Department of Cardiology and Angiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Pokaż więcej
    Źródło:
    Journal of translational medicine [J Transl Med] 2023 May 12; Vol. 21 (1), pp. 319. Date of Electronic Publication: 2023 May 12.
    Typ publikacji:
    Observational Study; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Proteome*
    Extracorporeal Membrane Oxygenation*/adverse effects
    Extracorporeal Membrane Oxygenation*/methods
    Humans ; Inflammation/etiology ; Survivors ; Hospital Mortality ; Retrospective Studies ; Shock, Cardiogenic/etiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    An activation specific anti-Mac-1 designed ankyrin repeat protein improves survival in a mouse model of acute lung injury.
    Autorzy:
    Siegel PM; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
    Przewosnik AS; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
    Wrobel J; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
    Heidt T; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
    Moser M; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
    Peter K; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.; Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia.; Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia.
    Bode C; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
    Diehl P; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
    Bojti I; Department of Cardiology and Angiology I, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2022 Apr 15; Vol. 12 (1), pp. 6296. Date of Electronic Publication: 2022 Apr 15.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Acute Lung Injury*/metabolism
    Respiratory Distress Syndrome*/drug therapy
    Animals ; Ankyrin Repeat ; Anti-Inflammatory Agents/pharmacology ; Bronchoalveolar Lavage Fluid ; Disease Models, Animal ; Lipopolysaccharides/metabolism ; Lung/pathology ; Macrophage-1 Antigen/metabolism ; Mice ; Weight Loss
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    P 2 Y 12 receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells.
    Autorzy:
    Siegel PM; Department of Cardiology and Angiology I, Faculty of Medicine, University Heart Center Freiburg - Bad Krozingen, University of Freiburg, Freiburg, Germany.; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
    Sander L; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
    Fricke A; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
    Stamm J; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
    Wang X; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.; Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia.; Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia.
    Sharma P; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
    Bassler N; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
    Ying YL; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.
    Olivier CB; Department of Cardiology and Angiology I, Faculty of Medicine, University Heart Center Freiburg - Bad Krozingen, University of Freiburg, Freiburg, Germany.
    Eisenhardt SU; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.; Department of Plastic and Hand Surgery, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Bode C; Department of Cardiology and Angiology I, Faculty of Medicine, University Heart Center Freiburg - Bad Krozingen, University of Freiburg, Freiburg, Germany.
    Ahrens I; Department of Cardiology and Angiology I, Faculty of Medicine, University Heart Center Freiburg - Bad Krozingen, University of Freiburg, Freiburg, Germany.; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.; Department of Cardiology and Medical Intensive Care, Augustinerinnen Hospital, Cologne, Germany.
    Diehl P; Department of Cardiology and Angiology I, Faculty of Medicine, University Heart Center Freiburg - Bad Krozingen, University of Freiburg, Freiburg, Germany.; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia.; Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia.
    Peter K; Department of Cardiology and Angiology I, Faculty of Medicine, University Heart Center Freiburg - Bad Krozingen, University of Freiburg, Freiburg, Germany. .; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia. .; Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia. .; Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia. .
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2021 Aug 31; Vol. 11 (1), pp. 17459. Date of Electronic Publication: 2021 Aug 31.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Acute Coronary Syndrome/*pathology
    Anti-Inflammatory Agents/*pharmacology
    Coronary Artery Disease/*pathology
    Inflammation/*drug therapy
    Macrophages/*drug effects
    Monocytes/*drug effects
    Purinergic P2Y Receptor Antagonists/*pharmacology
    Acute Coronary Syndrome/blood ; Adenosine Diphosphate/metabolism ; Case-Control Studies ; Coronary Artery Disease/blood ; Humans ; Inflammation/metabolism ; Inflammation/pathology ; Macrophages/metabolism ; Monocytes/metabolism ; Phosphorylation ; Receptors, Purinergic P2Y12 ; THP-1 Cells
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Coronary magnetic resonance imaging after routine implantation of bioresorbable vascular scaffolds allows non-invasive evaluation of vascular patency.
    Autorzy:
    von Zur Mühlen C; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Reiss S; Department of Radiology-Medical Physics, University Medical Center Freiburg, Freiburg, Germany.
    Krafft AJ; Department of Radiology-Medical Physics, University Medical Center Freiburg, Freiburg, Germany.
    Besch L; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Menza M; Department of Radiology-Medical Physics, University Medical Center Freiburg, Freiburg, Germany.
    Zehender M; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Heidt T; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Maier A; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Pfannebecker T; ABBOTT Vascular, Wetzlar, Germany.
    Zirlik A; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Reinöhl J; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Stachon P; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Hilgendorf I; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Wolf D; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Diehl P; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Wengenmayer T; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Ahrens I; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Bode C; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
    Bock M; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Radiology-Medical Physics, University Medical Center Freiburg, Freiburg, Germany.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2018 Jan 25; Vol. 13 (1), pp. e0191413. Date of Electronic Publication: 2018 Jan 25 (Print Publication: 2018).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Absorbable Implants*/adverse effects
    Vascular Patency*
    Angina Pectoris/*diagnostic imaging
    Angina Pectoris/*etiology
    Magnetic Resonance Angiography/*methods
    Percutaneous Coronary Intervention/*adverse effects
    Aged ; Humans ; Imaging, Three-Dimensional/methods ; Middle Aged ; Polyesters ; Tissue Scaffolds/adverse effects ; Tissue Scaffolds/chemistry
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y12-Dependent Platelet Inhibition Independently of the Platelet Count.
    Autorzy:
    Olivier CB; Heart Center Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
    Meyer M; Heart Center Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
    Bauer H; Munich University Hospital, Institute and Outpatient Clinic for Occupational, Social, and Environmental Medicine, Munich, Germany.
    Schnabel K; Heart Center Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
    Weik P; Heart Center Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
    Zhou Q; Heart Center Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
    Bode C; Heart Center Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
    Moser M; Heart Center Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
    Diehl P; Heart Center Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2016 Feb 17; Vol. 11 (2), pp. e0149053. Date of Electronic Publication: 2016 Feb 17 (Print Publication: 2016).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Adenosine Diphosphate/*pharmacology
    Oligopeptides/*pharmacology
    Platelet Aggregation/*drug effects
    Receptors, Purinergic P2Y12/*metabolism
    Aged ; Biomarkers/metabolism ; Female ; Humans ; Male ; Platelet Count ; Regression Analysis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-6 z 6

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies